J P Donnelly Selected Research

J P Donnelly Research Topics

Disease

12	Mucositis 04/2014 - 06/2000
9	Neutropenia 04/2014 - 01/2001
8	Neoplasms (Cancer) 01/2018 - 05/2002
7	Aspergillosis 11/2021 - 06/2000
7	Infections 03/2012 - 11/2000
6	Mycoses (Diseases, Fungus) 04/2015 - 06/2000
5	Candidiasis (Moniliasis) 12/2012 - 06/2000
5	Fever (Fevers) 09/2011 - 11/2000
4	Stomatitis 09/2007 - 04/2004
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 04/2004
3	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2014 - 11/2000
3	Atrophy 08/2010 - 02/2004
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2013 - 09/2006
2	Inflammation (Inflammations) 04/2008 - 11/2000
2	Invasive Fungal Infections 11/2007 - 05/2002
1	Disease Progression 11/2021
1	Bacteremia 04/2014
1	Citrullinemia 04/2014
1	Thrombosis (Thrombus) 02/2014
1	Thrombophlebitis 02/2014
1	Febrile Neutropenia 01/2014
1	Epstein-Barr Virus Infections 11/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2012
1	Oral Candidiasis (Thrush) 12/2012
1	Anastomotic Leak 12/2012
1	Sepsis (Septicemia) 09/2011
1	Intestinal Failure 08/2010
1	Invasive Candidiasis 04/2009
1	Multiple Myeloma 01/2009
1	Hematologic Neoplasms (Hematological Malignancy) 04/2008
1	Zygomycosis (Phycomycosis) 11/2007
1	Necrosis 02/2004
1	Bacterial Infections (Bacterial Infection) 11/2000
1	Communicable Diseases (Infectious Diseases) 06/2000

Drug/Important Bio-Agent (IBA)

7	CitrullineIBA 04/2014 - 08/2004
4	C-Reactive ProteinIBA 04/2014 - 11/2000
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2014 - 01/2001
4	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 02/2009 - 01/2001
3	Melphalan (Alkeran)FDA LinkGeneric 04/2014 - 01/2009
3	Fluconazole (Zonal)FDA LinkGeneric 12/2012 - 12/2012
2	Rituximab (Mabthera)FDA Link 11/2013 - 09/2006
2	Itraconazole (Sporanox)FDA LinkGeneric 12/2012 - 01/2004
2	Voriconazole (Vfend)FDA LinkGeneric 12/2012 - 11/2007
2	AzolesIBA 12/2012 - 12/2012
2	liposomal amphotericin B FDA Link 12/2012 - 12/2012
2	Pharmaceutical PreparationsIBA 12/2012 - 03/2004
2	Cytostatic AgentsIBA 09/2007 - 02/2004
2	galactomannanIBA 09/2006 - 10/2000
2	AntigensIBA 09/2006 - 06/2002
2	SugarsIBA 10/2005 - 04/2004
2	Biomarkers (Surrogate Marker)IBA 03/2005 - 08/2004
2	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2004 - 01/2001
1	Adenosine Monophosphate (AMP)IBA 11/2021
1	TriazolesIBA 01/2018
1	Anidulafungin FDA Link 04/2015
1	fludarabineIBA 04/2014
1	CoagulaseIBA 02/2014
1	Fibroblast Growth Factor 7 FDA Link 01/2014
1	Flucytosine (Ancobon)FDA Link 12/2012
1	SolutionsIBA 12/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2011
1	Amino Acids FDA Link 08/2010
1	AntibodiesIBA 04/2009
1	MannansIBA 04/2009
1	LactoferrinIBA 04/2008
1	RhamnoseIBA 10/2005
1	DipeptidesIBA 10/2005
1	Glutamine (L-Glutamine)FDA Link 10/2005
1	Lactulose (Duphalac)FDA LinkGeneric 10/2005
1	Interleukin-8 (Interleukin 8)IBA 10/2005
1	AnthracyclinesIBA 04/2005
1	NF-kappa B (NF-kB)IBA 02/2004
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 02/2004
1	Methotrexate (Mexate)FDA LinkGeneric 02/2004
1	CurcuminIBA 02/2004
1	Sodium Glutamate (Accent)IBA 05/2002
1	GlycopeptidesIBA 01/2001
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2001
1	Piperacillin FDA LinkGeneric 01/2001
1	Ceftazidime (Fortum)FDA LinkGeneric 01/2001
1	ProcalcitoninIBA 11/2000

Therapy/Procedure

13	Therapeutics 04/2014 - 01/2001
10	Stem Cell Transplantation 02/2014 - 06/2000
9	Drug Therapy (Chemotherapy) 01/2018 - 01/2004
5	Transplantation 02/2014 - 06/2000
2	Catheters 02/2014 - 01/2001
1	Artificial Respiration (Mechanical Ventilation) 02/2014
1	Highly Active Antiretroviral Therapy (HAART) 12/2012
1	Critical Care (Surgical Intensive Care) 12/2012
1	Hematopoietic Stem Cell Transplantation 04/2008
1	Aftercare (After-Treatment) 11/2007
1	Length of Stay 10/2005
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2000